Analysis Group Promotes Five Consultants to Managing Principal, Principal
April 22, 2013
Analysis Group announces the promotion of Mark Howrey and Alan White to Managing Principal; and George Kosicki, David Sosa, and Robert Vigil to Principal.
"Mark, Alan, George, David, and Robert -- experts in their respective fields of finance, antitrust, telecommunications, health care, tax, and intellectual property -- have delivered top-quality solutions to their clients and to the firm over the years," said President and CEO Martha S. Samuelson. "We are pleased to recognize their accomplishments, and we look forward to their continued success."
New Managing Principals
Mark Howrey has consulted to clients and supported testifying experts in matters involving finance, securities, and complex damages analyses. He has conducted analyses of market efficiency, examined loss causation and materiality, calculated damages, and assessed settlements in numerous securities matters involving alleged violations of Sections 10b-5, 11, and 12. Most recently, Mr. Howrey has consulted to large U.S. financial institutions in matters relating to the financial crisis and the decline of the mortgage industry.
Alan White focuses on antitrust, intellectual property, and tax matters in a range of industries, with a particular interest in health care issues. He has supported general commercial business litigations involving allegations of false advertising and breach of contract, investigations into alleged off-label promotion of prescription drugs, and the economic impact of generic substitution. He has also analyzed economic issues relevant to class certification and the quantification of damages. Dr. White's research and publications have focused on specific health economics issues, such as the costs of abuse, as well as the theory behind and implementation of various price indexes.
George Kosicki specializes in applied microeconomics and has consulted in the areas of antitrust, mergers and acquisitions, agricultural economics, labor economics, corporate finance, and commercial damages. He has also served as an expert witness on market definition, liability, and damages issues. Dr. Kosicki has worked extensively on the economics of cost pass-through and damages in indirect purchaser antitrust litigation. His consulting experience spans a wide range of industries, including agriculture, pharmaceuticals, medical devices, airlines, and railroads. His research has been published in several peer-reviewed journals.
David Sosa focuses on the economics of network industries, law and economics, and industrial organization. He has consulted to telecommunications and electric utility clients on a variety of litigation and regulatory issues, including industry restructuring, technical standardization, operational and financial benchmarking, mergers and acquisitions, market power analysis, and competitive strategy. Dr. Sosa has served as an expert witness before several state and federal agencies, and he has supported testifying experts in assessing the economic impacts of several high-profile mergers in the telecommunications industry. He has analyzed spectrum license acquisitions, wireless technology standards, and voice and data roaming markets, and he has consulted to telecommunications carriers in Latin America, Europe, and Asia on issues related to competition, regulation, and litigation. In addition, Dr. Sosa has performed damages and valuation analyses for clients in a broad range of litigation matters, including consumer class actions, intellectual property, employment, bankruptcy, and commercial contracts.
Robert Vigil applies economics and finance to complex commercial litigation matters. His work includes the estimation of damages and unjust enrichment in intellectual property and breach of contract cases; the evaluation of patented drug products' commercial success in connection with generic manufacturers' Abbreviated New Drug Application submissions to obtain early market entry; and the analysis of issues related to the granting of permanent injunctions, such as irreparable harm and causal nexus. Dr. Vigil has also analyzed issues related to domestic industry, remedy, and bonding on cases before the International Trade Commission. He has served as an expert witness on litigation matters in a variety of industries, including pharmaceuticals, medical devices, consumer products, computer hardware and software, and electronics.
Read the press release